{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T00:01:07Z","timestamp":1793923267169,"version":"4.8.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T00:00:00Z","timestamp":1780704000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"vor","delay-in-days":74,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-56514-5","type":"journal-article","created":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T05:39:09Z","timestamp":1780724349000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Minimal clinically important difference for cognitive scales in people with Parkinson\u2019s disease with cognitive impairment"],"prefix":"10.1038","volume":"16","author":[{"given":"Ghorban","family":"Taghizadeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0795-8732","authenticated-orcid":false,"given":"Negin","family":"Eissazade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Pagonabarraga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saul","family":"Martinez-Horta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime","family":"Kulisevsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7841-7979","authenticated-orcid":false,"given":"Parvaneh","family":"Taghavi Azar Sharabiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azar","family":"Sharabiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pouria","family":"Akbarikoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyede Zohreh","family":"Jazaeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2977-3421","authenticated-orcid":false,"given":"Maryam","family":"Mehdizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,6]]},"reference":[{"key":"56514_CR1","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1007\/s13311-020-00963-x","volume":"17","author":"Q Zhang","year":"2020","unstructured":"Zhang, Q., Aldridge, G. M., Narayanan, N. S., Anderson, S. W. & Uc, E. Y. Approach to cognitive impairment in Parkinson\u2019s disease. Neurotherapeutics 17, 1495\u20131510. https:\/\/doi.org\/10.1007\/s13311-020-00963-x (2020).","journal-title":"Neurotherapeutics"},{"key":"56514_CR2","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1080\/13803395.2015.1073227","volume":"37","author":"LF Vasconcellos","year":"2015","unstructured":"Vasconcellos, L. F. & Pereira, J. S. Parkinson\u2019s disease dementia: Diagnostic criteria and risk factor review. J. Clin. Exp. Neuropsychol. 37, 988\u2013993. https:\/\/doi.org\/10.1080\/13803395.2015.1073227 (2015).","journal-title":"J. Clin. Exp. Neuropsychol."},{"key":"56514_CR3","doi-asserted-by":"publisher","unstructured":"B\u00e4ckstr\u00f6m, D. et al. Early predictors of mortality in parkinsonism and Parkinson disease: A population-based study. Neurology 91, e2045-e (2056). https:\/\/doi.org\/10.1212\/wnl.0000000000006576 (2018).","DOI":"10.1212\/wnl.0000000000006576"},{"key":"56514_CR4","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.3390\/medicina59101756","volume":"59","author":"Y Degirmenci","year":"2023","unstructured":"Degirmenci, Y., Angelopoulou, E., Georgakopoulou, V. E. & Bougea, A. Cognitive impairment in Parkinson\u2019s disease: An updated overview focusing on emerging pharmaceutical treatment approaches. Medicina 59, 1756 (2023).","journal-title":"Medicina"},{"key":"56514_CR5","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/j.jseint.2021.05.003","volume":"5","author":"D Gordon","year":"2021","unstructured":"Gordon, D. et al. Minimal clinically important difference, substantial clinical benefit, and patient acceptable symptom state of PROMIS upper extremity after total shoulder arthroplasty. JSES Int. 5, 894\u2013899. https:\/\/doi.org\/10.1016\/j.jseint.2021.05.003 (2021).","journal-title":"JSES Int."},{"key":"56514_CR6","doi-asserted-by":"publisher","unstructured":"Migliorini, F. et al. Minimal clinically important difference (MCID), substantial clinical benefit (SCB), and patient-acceptable symptom state (PASS) in patients who have undergone total knee arthroplasty: A systematic review. Knee Surg. Relat. Res. 36 https:\/\/doi.org\/10.1186\/s43019-024-00210-z (2024).","DOI":"10.1186\/s43019-024-00210-z"},{"key":"56514_CR7","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.parkreldis.2011.02.018","volume":"17","author":"KR Chaudhuri","year":"2011","unstructured":"Chaudhuri, K. R., Odin, P., Antonini, A. & Martinez-Martin, P. Parkinson\u2019s disease: The non-motor issues. Parkinsonism Relat. Disord. 17, 717\u2013723. https:\/\/doi.org\/10.1016\/j.parkreldis.2011.02.018 (2011).","journal-title":"Parkinsonism Relat. Disord"},{"key":"56514_CR8","doi-asserted-by":"publisher","first-page":"118284","DOI":"10.1016\/j.socscimed.2025.118284","volume":"381","author":"SF Poon","year":"2025","unstructured":"Poon, S. F., Tan, C. H., Hong, W. P., Chen, K. C. & Yu, R. L. Tailoring anxiety assessment for Parkinson\u2019s disease: The Chinese Parkinson anxiety scale with cultural and situational anxiety considerations. Soc. Sci. Med. 381, 118284. https:\/\/doi.org\/10.1016\/j.socscimed.2025.118284 (2025).","journal-title":"Soc. Sci. Med."},{"key":"56514_CR9","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1002\/mds.22007","volume":"23","author":"J Pagonabarraga","year":"2008","unstructured":"Pagonabarraga, J. et al. Parkinson\u2019s disease-cognitive rating scale: A new cognitive scale specific for Parkinson\u2019s disease. Mov. Disord. 23, 998\u20131005. https:\/\/doi.org\/10.1002\/mds.22007 (2008).","journal-title":"Mov. Disord"},{"key":"56514_CR10","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1212\/01.WNL.0000091864.39702.1C","volume":"61","author":"J Marinus","year":"2003","unstructured":"Marinus, J. et al. Assessment of cognition in Parkinson\u2019s disease. Neurology 61, 1222\u20131228. https:\/\/doi.org\/10.1212\/01.WNL.0000091864.39702.1C (2003).","journal-title":"Neurology"},{"key":"56514_CR11","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","volume":"53","author":"ZS Nasreddine","year":"2005","unstructured":"Nasreddine, Z. S. et al. The montreal cognitive assessment, MoCA: A brief screening tool for mild cognitive impairment. J. Am. Geriatr. Soc. 53, 695\u2013699. https:\/\/doi.org\/10.1111\/j.1532-5415.2005.53221.x (2005).","journal-title":"J. Am. Geriatr. Soc."},{"key":"56514_CR12","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/ene.12022","volume":"20","author":"A Berardelli","year":"2013","unstructured":"Berardelli, A. et al. EFNS\/MDS-ES\/ENS [corrected] recommendations for the diagnosis of Parkinson\u2019s disease. Eur. J. Neurol. 20, 16\u201334. https:\/\/doi.org\/10.1111\/ene.12022 (2013).","journal-title":"Eur. J. Neurol."},{"key":"56514_CR13","doi-asserted-by":"publisher","first-page":"168","DOI":"10.3390\/brainsci12020168","volume":"12","author":"B Span\u00f2","year":"2022","unstructured":"Span\u00f2, B. et al. Effect of dual-task motor-cognitive training in preventing falls in vulnerable elderly cerebrovascular patients: A pilot study. Brain Sci. 12, 168 (2022).","journal-title":"Brain Sci."},{"key":"56514_CR14","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1179\/jmt.2009.17.3.163","volume":"17","author":"SJ Kamper","year":"2009","unstructured":"Kamper, S. J., Maher, C. G. & Mackay, G. Global rating of change scales: A review of strengths and weaknesses and considerations for design. J. Man. Manip Ther. 17, 163\u2013170. https:\/\/doi.org\/10.1179\/jmt.2009.17.3.163 (2009).","journal-title":"J. Man. Manip Ther."},{"key":"56514_CR15","first-page":"28","volume":"4","author":"J Busner","year":"2007","unstructured":"Busner, J. & Targum, S. D. The clinical global impressions scale: Applying a research tool in clinical practice. Psychiatry (Edgmont). 4, 28\u201337 (2007).","journal-title":"Psychiatry (Edgmont)"},{"key":"56514_CR16","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.jclinepi.2007.03.012","volume":"61","author":"D Revicki","year":"2008","unstructured":"Revicki, D., Hays, R. D., Cella, D. & Sloan, J. Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes. J. Clin. Epidemiol. 61, 102\u2013109. https:\/\/doi.org\/10.1016\/j.jclinepi.2007.03.012 (2008).","journal-title":"J. Clin. Epidemiol."},{"key":"56514_CR17","doi-asserted-by":"publisher","first-page":"e205","DOI":"10.1192\/bjo.2022.611","volume":"8","author":"YR Chen","year":"2022","unstructured":"Chen, Y. R. et al. Investigating the interaction between neuropsychiatry features and daily activities on social function in patients with Parkinson\u2019s disease with mild cognitive impairment. BJPsych Open. 8, e205. https:\/\/doi.org\/10.1192\/bjo.2022.611 (2022).","journal-title":"BJPsych Open."},{"key":"56514_CR18","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/0197-2456(89)90005-6","volume":"10","author":"R Jaeschke","year":"1989","unstructured":"Jaeschke, R., Singer, J. & Guyatt, G. H. Measurement of health status. Ascertaining the minimal clinically important difference. Control Clin. Trials. 10, 407\u2013415. https:\/\/doi.org\/10.1016\/0197-2456(89)90005-6 (1989).","journal-title":"Control Clin. Trials"},{"key":"56514_CR19","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1080\/09638288.2020.1813337","volume":"44","author":"A Mahmoudi Asl","year":"2022","unstructured":"Mahmoudi Asl, A. et al. Reliability, validity, and diagnostic accuracy of Parkinson\u2019s Disease-Cognitive Rating Scale in Iranian patients with idiopathic Parkinson\u2019s disease. Disabil. Rehabil. 44, 2091\u20132098. https:\/\/doi.org\/10.1080\/09638288.2020.1813337 (2022).","journal-title":"Disabil. Rehabil"},{"key":"56514_CR20","doi-asserted-by":"publisher","unstructured":"Fereshtehnejad, S. M. et al. Cross-cultural validity, reliability, and psychometric properties of the persian version of the scales for outcomes in Parkinson\u2019s disease-psychosocial questionnaire. Neurol Res Int 260684, (2014). https:\/\/doi.org\/10.1155\/2014\/260684 (2014).","DOI":"10.1155\/2014\/260684"},{"key":"56514_CR21","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1080\/23279095.2019.1565762","volume":"27","author":"SZ Badrkhahan","year":"2020","unstructured":"Badrkhahan, S. Z., Sikaroodi, H., Sharifi, F., Kouti, L. & Noroozian, M. Validity and reliability of the Persian version of the Montreal Cognitive Assessment (MoCA-P) scale among subjects with Parkinson\u2019s disease. Appl. Neuropsychol. Adult. 27, 431\u2013439. https:\/\/doi.org\/10.1080\/23279095.2019.1565762 (2020).","journal-title":"Appl. Neuropsychol. Adult"},{"key":"56514_CR22","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1002\/mds.25568","volume":"28","author":"R de Fern\u00e1ndez","year":"2013","unstructured":"de Fern\u00e1ndez, R. et al. Parkinson\u2019s disease-cognitive rating scale: psychometrics for mild cognitive impairment. Mov. Disord. 28, 1376\u20131383. https:\/\/doi.org\/10.1002\/mds.25568 (2013).","journal-title":"Mov. Disord"},{"key":"56514_CR23","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1080\/09638288.2022.2074152","volume":"45","author":"G Taghizadeh","year":"2023","unstructured":"Taghizadeh, G., Fereshtehnejad, S. M., Goudarzi, S., Jamali, S. & Mehdizadeh, M. Minimal clinically important difference of the King\u2019s Parkinson\u2019s disease Pain Scale. Disabil. Rehabil. 45, 1680\u20131683 (2023).","journal-title":"Disabil. Rehabil."},{"key":"56514_CR24","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/j.jpainsymman.2017.10.014","volume":"55","author":"A Chan","year":"2018","unstructured":"Chan, A. et al. Minimal clinically important difference of the multidimensional fatigue symptom inventory-short form (MFSI-SF) for fatigue worsening in asian breast cancer patients. J. Pain Symptom Manage. 55, 992\u2013997e992. https:\/\/doi.org\/10.1016\/j.jpainsymman.2017.10.014 (2018).","journal-title":"J. Pain Symptom Manage."},{"key":"56514_CR25","doi-asserted-by":"publisher","first-page":"100222","DOI":"10.1016\/j.cccb.2024.100222","volume":"6","author":"E Lindvall","year":"2024","unstructured":"Lindvall, E., Abzhandadze, T., Quinn, T. J., Sunnerhagen, K. S. & Lundstr\u00f6m, E. Is the difference real, is the difference relevant: the minimal detectable and clinically important changes in the Montreal Cognitive Assessment. Cereb. Circ. Cogn. Behav. 6, 100222. https:\/\/doi.org\/10.1016\/j.cccb.2024.100222 (2024).","journal-title":"Cereb. Circ. Cogn. Behav."},{"key":"56514_CR26","doi-asserted-by":"publisher","unstructured":"Wu, C. Y. et al. Responsiveness, Minimal clinically important difference, and validity of the MoCA in stroke rehabilitation. Occup Ther Int 2517658, (2019). https:\/\/doi.org\/10.1155\/2019\/2517658 (2019).","DOI":"10.1155\/2019\/2517658"},{"key":"56514_CR27","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jocn.2017.08.039","volume":"46","author":"GKC Wong","year":"2017","unstructured":"Wong, G. K. C. et al. Minimum clinically important difference of montreal cognitive assessment in aneurysmal subarachnoid hemorrhage patients. J. Clin. Neurosci. 46, 41\u201344. https:\/\/doi.org\/10.1016\/j.jocn.2017.08.039 (2017).","journal-title":"J. Clin. Neurosci."},{"key":"56514_CR28","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1179\/2042618612y.0000000001","volume":"20","author":"A Wright","year":"2012","unstructured":"Wright, A., Hannon, J., Hegedus, E. J. & Kavchak, A. E. Clinimetrics corner: A closer look at the minimal clinically important difference (MCID). J. Man. Manip Ther. 20, 160\u2013166. https:\/\/doi.org\/10.1179\/2042618612y.0000000001 (2012).","journal-title":"J. Man. Manip Ther."},{"key":"56514_CR29","doi-asserted-by":"publisher","first-page":"e10259","DOI":"10.1016\/j.heliyon.2022.e10259","volume":"8","author":"SP Holm","year":"2022","unstructured":"Holm, S. P., Wolfer, A. M., Pointeau, G. H. S., Lipsmeier, F. & Lindemann, M. Practice effects in performance outcome measures in patients living with neurologic disorders\u2013A systematic review. Heliyon 8, e10259. https:\/\/doi.org\/10.1016\/j.heliyon.2022.e10259 (2022).","journal-title":"Heliyon"},{"key":"56514_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/arclin\/acad046","volume":"39","author":"K Duff","year":"2024","unstructured":"Duff, K., Dixon, A. & Embree, L. A closer look at practice effects in mild cognitive impairment and Alzheimer\u2019s disease. Arch. Clin. Neuropsychol. 39, 1\u201310. https:\/\/doi.org\/10.1093\/arclin\/acad046 (2024).","journal-title":"Arch. Clin. Neuropsychol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-56514-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-56514-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-56514-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:05:37Z","timestamp":1787097937000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-56514-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,6]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["56514"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-56514-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,6]]},"assertion":[{"value":"17 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interest.","order":1,"name":"Ethics","label":"Competing interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"26025"}}